We have examined the opsonic activity of sera from patients with Neisseria meningitidis (B:15:P1.16) infections against different meningococcal strains, using flow cytometry and luminol-enhanced chemiluminescence. A marked increase in the phagocytosis of ethanol-fixed meningococcal strains of different serogroups, serotypes, and serosubtypes was demonstrated in the presence of convalescence sera compared with acute sera. Convalescence sera also caused a significant increase of leukocyte oxidative metabolism during phagocytosis, as measured by luminol-enhanced chemiluminescence. The sera contained a broad range of opsonins crossreacting with serogroup A, B, C, W-135, and Y meningococci of different serotypes and serosubtypes, indicating that the cross-reacting opsonins recognized surface epitopes other than those determined by current serotyping schemes.
Patients with meningococcal disease develop serum antibodies against different capsular and outer membrane antigens. Although these antibodies confer opsonic (10, 20, 23) as well as bactericidal (7) function, the susceptibility to systemic disease has been related to the lack of bactericidal antibodies to pathogenic strains of Neisseria meningitidis (7) . However, more recent studies have indicated that opsonic antibodies may play a role in the defense against group B meningococcal disease (10, 18, 22) .
Antibodies directed against meningococcal outer membrane antigens can cross-react with outer membrane antigens from heterologous strains. Cross-reacting antibodies have been detected against meningococcal minor outer membrane proteins, major outer membrane proteins (class 2 and class 3), lipopolysaccharide, and pili (15, 17) . Poolman et al. (17) have shown in nonfunctional assays that convalescence sera from patients with meningococcal disease show significant cross-reactivity against outer membrane complexes from heterologous meningococcal strains. Crossreacting bactericidal antibodies have been demonstrated in patients with meningococcal disease (12) and in vaccinees immunized with meningococcal group B outer membrane vesicles (11) . There is evidence of cross-reacting serum opsonins in convalescence sera from patients with meningococcal disease (10, 13) , but little is known about the extent of this opsonic cross-reactivity.
The ongoing epidemic of meningococcal group B disease in Norway has been dominated by serotype 15 (6) . Since opsonophagocytosis of meningococci seems to be of importance in the defense against group B meningococcal disease (10, 18, 22) , we (Table 2) were grown overnight on DST-blood agar in resuspended in HBSS (pH 7.4), counted by flow cytometry, a 5% CO2 atmosphere at 37°C, inoculated in heart infusion adjusted to 5 x 108 bacteria per ml, and stored in aliquots at broth to an optical density of 0.4 at 620 nm, using a 10-mm -70°C (1, 3). light path, and grown to logarithmic growth phase in a Flow cytometry assay. Bacterial suspensions (2.5 x 107 shaking water bath at 37°C (3 to 4 h, interstrain variations). bacteria in HBSS) and sera (final concentration of 5%) were The bacteria were washed three times in ice-cold 0.9% NaCl mixed in plastic tubes by end-over-end rotation for 7.5 min at (2,500 x g for 10 min at 4°C), resuspended in HBSS (pH 7.4), 37°C. Titration of sera showed that 5% was sufficient for and adjusted to an optical density of 1.0, and CFU per maximal phagocytosis, and heat treatment of sera (56°C for milliliter was determined. The bacteria were not killed by 30 min) reduced the phagocytosis to 10 to 20% of the level this procedure.
obtained with non-heat-treated sera. After opsonization, 0.1 Ethanol fixation of the bacteria. Suspensions of bacteria ml of the leukocyte suspension was added to give a ratio of were centrifuged (2,500 x g for 10 min at 4°C), resuspended 20 bacteria per nonlymphocyte. Phagocytosis was termiin an equal volume of ice-cold 70% ethanol, and kept on ice nated after 7.5 min by adding 1 ml of ice-cold PBS supplefor 1 h. After three washes in ice-cold 0.9% NaCl, the mented with 0.02% EDTA. The suspensions were analyzed bacteria intended for chemiluminescence assays were resusby a Coulter EPICS V flow cytometer with a 488-nm argon pended in HBSS (pH 7.4), counted in a counting chamber laser, interfaced to a MDADS computer (Coulter Electronics (Thoma, Karl Hecht, Sonderheim, Germany), adjusted to 5 Ltd., Luton, England) (1, 3). A 530-nm band pass filter was x 108 bacteria per ml, and stored in aliquots at -70°C. The used for measurements of FITC fluorescence. ethanol-fixed and unfixed bacteria gave identical results by Flow cytometry parameters of phagocytosis. FITC-labeled (Fig. 3) . The A significantly lower chemiluminescence response was observed with use of the serotype 2a or 2b strains containing class 2 outer membrane protein than with use of serotype 15 strains (class 3) regardless of the serogroup (P < 0.05, using the Mann-Whitney test). The oxidative response during phagocytosis of the nonencapsulated variant of the B:2a: P1.2 strain was twice as high as that of the encapsulated parent strain.
There was minimal chemiluminescence activity in the absence of serum. No increase in the polymorphonuclear leukocyte oxidative metabolism was demonstrated during the phagocytosis of different strains of H. influenzae type b, S. pneumoniae type 1, and S. epidermidis tested with convalescence sera compared with acute sera from patients with meningococcal disease (data not shown). cence sera from patients with meningococcal group B disease and in sera from vaccinees immunized with meningococcal group B outer membrane vesicles (10-13, 15, 17) . Such cross-reacting antibodies have been shown in quantitative, nonfunctional assays (15, 17) as well as in bactericidal assays (11, 12) . However, little is known about the extent of opsonic cross-reactivity in convalescence sera toward meningococci of other serogroups, serotypes, and serosubtypes than those of the infecting strain (10, 13) . In the present study, we have examined the presence of cross-reacting opsonins in convalescence sera from patients with N. meningitidis (B:15:P1.16) infections. The opsonophagocytosis was determined by flow cytometry, and the leukocyte oxidative burst during phagocytosis was quantitated by luminolenhanced chemiluminescence. Cross-reacting serum opsonins were demonstrated against serogroup A, B, C, W-135, and Y meningococci of all serotypes and serosubtypes tested. Furthermore, the variations in the opsonophagocytosis of meningococci did not follow serotype and serosubtype patterns, indicating that opsonins cross-react with epitopes other than those defined by serotyping. This is in accordance with the results of previous studies using enzyme-linked immunosorbent assay and radioimmunoassay techniques (15, 17) .
In this study, laboratory strains of meningococci were more easily phagocytized than were recently isolated patient strains of the same serogroup, serotype, and serosubtype. Most likely, strains become attenuated and more susceptible to phagocyte ingestion during continued laboratory passages. In functional assays, it may thus be wise to include recently isolated patient strains in addition to well-characterized laboratory strains.
Usually, encapsulated bacteria are more resistant to phagocytosis than are nonencapsulated strains (24) . In 
